AI
Ainos, Inc.
AIMD · NASDAQ
$1.46 +0.00% (+$0.00)
1M +2.76%
Market Cap $10.6M
P/E Ratio -
Div. Yield -
ROE 217.50%
Bulios Fair Price
$2.16
47.9% upside
Current Price
$1.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AIMD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
32 /100
Expensive P/B 3.23x
P/S 779.78x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 39.78%
Rev. growth 67.20%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 101,210.00%
Gross margin 34,987.50%
FCF margin 33,046.90%
Quality
0 /100
Poor ROA 73.89%
ROIC 80.51%
Asset turnover 0.00x
Debt
0 /100
High Int. coverage -18.79x
Debt/Equity 4.21x
Current ratio 0.13x
Stability
1 /100
Unstable EPS volatility 96.25%
Beta 2.49x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AIMD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chun-Hsien Tsai
Employees
41
Headquarters
Houston